Search results
Results from the WOW.Com Content Network
Effects have included an increase in cannabis-related calls to the Oregon state poison center, [29] an increase in perception among youth that marijuana use is harmful, [29] a decrease in arrest rates for cannabis related offenses, [29] stores sold $250 million in cannabis products which resulted in $70 million in state tax revenue (higher than ...
However, medical marijuana treatments are not for everyone and it may cause adverse side effects for others. Overall, the potential long-term side effects of medical marijuana are not yet fully classified. As a result, further studies must carry out to fully understand the benefits as well as adverse psychiatric and medical side effects of the ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 3 February 2025. Issue around the legalisation of cannabis Part of a series on Cannabis Arts Culture 420 (chan) Books Magu (deity) Names Religion Judaism Latter-day Saints Sikhism Smoke-in Spiritual use Sports Stoner film Stoner rock Terms Chemistry Phytocannabinoids Main THC Dronabinol (INN) CBD Minor ...
Decriminalizing dilemma . Colorado has decriminalized some natural psychedelics, removing the criminal penalties around growing, possessing and using the drugs. If passed, the Massachusetts ...
Oregon, however, saw overdose deaths increase by 50% between 2021, when decriminalization went into effect, and 2023. Why there's debate There’s little question that the decriminalization of ...
The Marijuana Opportunity Reinvestment and Expungement Act, also known as the MORE Act, is a proposed piece of U.S. federal legislation that would deschedule cannabis from the Controlled Substances Act and enact various criminal and social justice reforms related to cannabis, including the expungement of prior convictions.
The legalization of marijuana can open up the possibility to regulate it. That regulation implies the opportunity to tax the drug, and it also makes law enforcement easier.
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]